Amcasertib

Unknown Manufacturer

Amcasertib is under investigation in clinical trial NCT02483247 (A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer).

Generate AI report

Overview

Amcasertib is under investigation in clinical trial NCT02483247 (A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer).

Technical identifiers

Chemical Formula: C₃₁H₃₃N₅O₂S
CAS Number: 1129403-56-0
UNII ID: GLY8ABW25V

Drugs